Literature DB >> 17234460

The autonomic nervous system and inflammatory bowel disease.

Cormac T Taylor1, Stephen J Keely.   

Abstract

Crohn's disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD), are chronic, recurring, inflammatory conditions of the intestine. The precise mechanisms underlying the pathogenesis of IBD are not yet clear but they are believed to involve a number of precipitating factors, most notably genetic susceptibility and environmental influences. The autonomic nervous system (ANS) has long been known as a critical regulator of intestinal function and much evidence now exists to suggest that it also plays an important role in the development of IBD. Dramatic changes in the ANS in IBD are apparent from the cellular to the molecular level ultimately leading to altered communication between the ANS and effector cells of the intestine. This review aims to synthesize the current understanding of the pathogenesis of IBD with a particular emphasis on the role that the ANS plays in the progression of these diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17234460     DOI: 10.1016/j.autneu.2006.11.005

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  15 in total

1.  Modeling the association between HR variability and illness in elite swimmers.

Authors:  Philippe Hellard; Fanny Guimaraes; Marta Avalos; Nicolas Houel; Christophe Hausswirth; Jean François Toussaint
Journal:  Med Sci Sports Exerc       Date:  2011-06       Impact factor: 5.411

2.  Thymic involution correlates with severe ulcerative colitis induced by oral administration of dextran sulphate sodium in C57BL/6 mice but not in BALB/c mice.

Authors:  Shin Sasaki; Yoshiyuki Ishida; Naomi Nishio; Sachiko Ito; Ken-ichi Isobe
Journal:  Inflammation       Date:  2008-10       Impact factor: 4.092

3.  Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values.

Authors:  Laura Mäkitalo; Taina Sipponen; Päivi Kärkkäinen; Kaija-Leena Kolho; Ulpu Saarialho-Kere
Journal:  Int J Colorectal Dis       Date:  2009-08-04       Impact factor: 2.571

4.  Optogenetic activation of local colonic sympathetic innervations attenuates colitis by limiting immune cell extravasation.

Authors:  Maya Schiller; Hilla Azulay-Debby; Nadia Boshnak; Yehezqel Elyahu; Ben Korin; Tamar L Ben-Shaanan; Tamar Koren; Maria Krot; Fahed Hakim; Asya Rolls
Journal:  Immunity       Date:  2021-04-30       Impact factor: 31.745

5.  Personality dimensions and type D personality in female patients with ulcerative colitis.

Authors:  Marzieh Sadat Sajadinejad; Hossein Molavi; Karim Asgari; Mehrdad Kalantari; Peyman Adibi
Journal:  J Res Med Sci       Date:  2012-10       Impact factor: 1.852

Review 6.  Neuroinflammation in inflammatory bowel disease.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  J Neuroinflammation       Date:  2010-07-08       Impact factor: 8.322

7.  Activated eosinophils in association with enteric nerves in inflammatory bowel disease.

Authors:  Claire M Smyth; Nadim Akasheh; Sara Woods; Elaine Kay; Ross K Morgan; Margaret A Thornton; Anthony O'Grady; Robert Cummins; Orla Sheils; Peter Smyth; Gerald J Gleich; Frank M Murray; Richard W Costello
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  The Gut's Little Brain in Control of Intestinal Immunity.

Authors:  Wouter J de Jonge
Journal:  ISRN Gastroenterol       Date:  2013-04-04

9.  Autonomic effects of music in health and Crohn's disease: the impact of isochronicity, emotional valence, and tempo.

Authors:  Roland Uwe Krabs; Ronny Enk; Niels Teich; Stefan Koelsch
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

10.  Involvement of MAPK/NF-κB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation.

Authors:  Peng Sun; Kewen Zhou; Sheng Wang; Ping Li; Sijuan Chen; Guiping Lin; Yan Zhao; Tinghuai Wang
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.